Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Ponce
    Ponce
  4. Dahi
    Dahi
  5. Jakubowski
    Jakubowski
  6. Papadopoulos
    Papadopoulos
  7. Shah
    Shah
  8. Sauter
    Sauter
  9. Barker
    Barker
  10. Devlin
    Devlin

Groups

  1. CTCR Scholars (219)
  2. MSK Grad Students (219)
  3. Master of Science in Clinical and Translational Cancer Research (219)
  4. Department of Medicine (217)
  5. Hematologic Malignancies, Division of (209)
  6. Center for Hematologic Malignancies (208)
  7. Bone Marrow Transplant (207)
  8. Survivorship Research (166)
  9. Biostatistics Service (111)
  10. Epidemiology and Biostatistics (111)
Search Within
  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (140)
  2. Journal Article (66)
  3. Review (8)
  4. Editorial (2)
  5. Guidelines (2)
  6. Book Section (1)
Groups
  1. CTCR Scholars (219)
  2. MSK Grad Students (219)
  3. Master of Science in Clinical and Translational Cancer Research (219)
  4. Department of Medicine (217)
  5. Hematologic Malignancies, Division of (209)
  6. Center for Hematologic Malignancies (208)

More Groups

People
  1. Sergio Giralt (159)
  2. Miguel-Angel Perales (133)
  3. Doris Ponce (108)
  4. Parastoo Dahi (104)
  5. Sean Devlin (103)
  6. Roni Tamari (87)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (28)
  5. 2021 (11)
  6. 2020 (30)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (153)
  2. Transplantation and Cellular Therapy (42)
  3. Clinical Lymphoma, Myeloma and Leukemia (6)
  4. International Journal of Radiation Oncology, Biology, Physics (5)
  5. European Journal of Cancer (3)
  6. Cancer Treatment Reviews (2)

More Publications

Results (219)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of “Donors for all”
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Daratumumab salvage therapy for refractory immune cytopenias after ALLOHCT
    Meeting Abstract

    Lin, A.; DeRespiris, L.; Chinapen, S.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Interim results of a pilot, prospective, randomized, double-blinded, vehicle-controlled trial on safety and efficacy of a topical inhibitor of Janus kinase 1/2 (ruxolitinib INCB018424 phosphate 1.5% cream) for non-sclerotic and superficially sclerotic chronic cutaneous graft-versus-host disease
    Meeting Abstract

    Markova, A.; Prockop, S. E.; Dusza, S.; Pan, A.; Chowdhury, A.; Lacouture, M. E.; Perales, M. A.; Ponce, D. M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Prolonged post-transplant ruxolitinib therapy is associated with protection from severe gvhd after allogeneic HCT
    Meeting Abstract

    DeFilipp, Z.; Kim, H. T.; Knight, L.; Kelley, D.; Byrne, M. T.; Schroeder, M. A.; Tamari, R.; Wall, S. A.; Vasu, S.; Abedin, S.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save